Cinchophen

CAS No. 132-60-5

Cinchophen( Cinchopen | Mylofanol | Agotan | Phenophan | Tervalon | NSC2617 )

Catalog No. M11303 CAS No. 132-60-5

Cinchophen is an analgesic drug that is frequently used to treat gout.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG 27 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Cinchophen
  • Note
    Research use only, not for human use.
  • Brief Description
    Cinchophen is an analgesic drug that is frequently used to treat gout.
  • Description
    Cinchophen is an analgesic drug that is frequently used to treat gout.(In Vivo):Cinchophen (oral gavage; 25-44 mg/kg; twice daily) combines prednisolone ( 0.125-0.220 mg/kg; twice daily) for 14 days is effective in dogs with osteoarthritis and well tolerated. The combination exhibits significantly improved lameness, weight bearing, joint mobility and stiffness scores and is similar in clinical efficacy to phenylbutazone.The kinetics and efficacy of a cinchophen prednisolone combination preparation (PLT) is tested. Cinchophen administation at a dose rate of 12.5 mg/kg intravenously exhibits a volume of distribution (Vd area) of 0.13 L/kg, shows a clearance rate (Cl) of 0.15 L/h and a half-life (t1/2β) of 7.92 hours. The plasma concentration time curve (AUC0-∞) is 1187.0 μ/ml.h in dogs.Cinchophen administation (oral gavage; 12.5 mg/kg; single dose) exhibits a mean maximum plasma concentration (Cmax) of 77.75 μg/ml and the time of Cmax (tmax) is 2.76 hours. The plasma concentration time curve (AUC0-∞) is almost as large following oral as intravenous administration indicating an oral bioavailability (F) of 87.21%.
  • In Vitro
    ——
  • In Vivo
    Cinchophen (oral gavage; 25-44 mg/kg; twice daily) combines prednisolone ( 0.125-0.220 mg/kg; twice daily) for 14 days is effective in dogs with osteoarthritis and well tolerated. The combination exhibits significantly improved lameness, weight bearing, joint mobility and stiffness scores and is similar in clinical efficacy to phenylbutazone.The kinetics and efficacy of a cinchophen prednisolone combination preparation (PLT) is tested. Cinchophen administation at a dose rate of 12.5 mg/kg intravenously exhibits a volume of distribution (Vd area) of 0.13 L/kg, shows a clearance rate (Cl) of 0.15 L/h and a half-life (t1/2β) of 7.92 hours. The plasma concentration time curve (AUC0-∞) is 1187.0 μ/ml.h in dogs.Cinchophen administation (oral gavage; 12.5 mg/kg; single dose) exhibits a mean maximum plasma concentration (Cmax) of 77.75 μg/ml and the time of Cmax (tmax) is 2.76 hours. The plasma concentration time curve (AUC0-∞) is almost as large following oral as intravenous administration indicating an oral bioavailability (F) of 87.21%.
  • Synonyms
    Cinchopen | Mylofanol | Agotan | Phenophan | Tervalon | NSC2617
  • Pathway
    Chromatin/Epigenetic
  • Target
    COX
  • Recptor
    COX
  • Research Area
    Inflammation/Immunology
  • Indication
    ——

Chemical Information

  • CAS Number
    132-60-5
  • Formula Weight
    249.26
  • Molecular Formula
    C16H11NO2
  • Purity
    >98% (HPLC)
  • Solubility
    Ethanol: 5 mg/mL (20.05 mM); DMSO: 50 mg/mL (200.59 mM)
  • SMILES
    O=C(O)C1=CC(C2=CC=CC=C2)=NC3=CC=CC=C13
  • Chemical Name
    2-Phenylcinchoninic acid

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Cutrín Prieto C, et al. Med Clin (Barc). 1991 Jun 15; 97(3):104-6.
molnova catalog
related products
  • Acetylsalicylic acid

    Aspirin (Acetylsalicylic acid) is a potent and selective inhibitor of cyclooxygenase (COX) with a broad range of pharmacological activities including anti-inflammation and pain relief.

  • Agnuside

    Agnuside inhibits COX-2 (IC50: 0.026 mg/ml) but exhibits less than 10% inhibition of COX-1 at this concentration. It also inhibits 46.3 66.8 and 82.1% of P-glycoprotein (P-gp) ATPase activity at concentrations of 5 25 and 100 μM respectively.

  • (+)-Catechin pentaac...

    (+)-Catechin pentaacetate (Catechin pentaacetate) is an esterified derivative of catechin with the potential to improve intestinal morphology and function and positively modulate the microbiome, and reduce iron and zinc transport proteins in the duodenum.